Research Awards to Fund Innovative Vision Science
Written By: BrightFocus Editorial Staff
Clarksburg, MD—BrightFocus Foundation, a premier private funder of vision research, today announced a request for proposals for projects supported through its Macular Degeneration Research program. The deadline for Letters of Intent is July 29, 2021 for projects beginning in 2022.
The grants cover a wide range of investigator-initiated topics to better understand, treat, and prevent age-related macular degeneration, a leading cause of blindness. With a strong emphasis on early career scientists and their new ideas, BrightFocus offers three levels of grants:
BrightFocus funding has blazed new trails of discovery, including breakthroughs that have led to multiple Nobel Prizes. “We encourage scientists from around the world to bring us their bold, high-impact ideas, the ‘what-if’s’ of science that may someday help save sight,” said Diane Bovenkamp, PhD, BrightFocus Vice President for Scientific Affairs.
Visit here for more information about the BrightFocus macular degeneration grants, including how to apply. Our most recent yearbook gives an overview of scientific projects the program is currently supporting around the globe.
BrightFocus Foundation is a premier global nonprofit funder of research to defeat Alzheimer’s, macular degeneration, and glaucoma. Since its inception more than 50 years ago, BrightFocus and its flagship research programs—Alzheimer’s Disease Research, Macular Degeneration Research, and National Glaucoma Research—has awarded more than $300 million in research grants to scientists around the world, catalyzing thousands of scientific breakthroughs, life-enhancing treatments, and diagnostic tools. We also share the latest research findings, expert information, and resources to empower the millions impacted by these devastating diseases. Learn more at brightfocus.org.
Disclaimer: The information provided here is a public service of BrightFocus Foundation and is not intended to constitute medical advice. Please consult your physician for personalized medical, dietary, and/or exercise advice. Any medications or supplements should only be taken under medical supervision. BrightFocus Foundation does not endorse any medical products or therapies.
A clinical trial for an investigational eye drop to treat wet age-related macular degeneration is seeking eligible participants for enrollment.
BrightFocus President and CEO Stacy Pagos Haller spoke with WebMD's Chief Medical Officer John Whyte, MD, MPH, as part of its “Champions for Change” series to discuss the progress being made to advance the understanding of geographic atrophy, which affects around 1 million people in the U.S.
BrightFocus Foundation, in partnership with three other global vision loss advocacy organizations, has declared Dec. 5 as World Geographic Atrophy Day.
BrightFocus Foundation’s second Macular Fast Track program will train promising graduate students, postdoctoral fellows, and other early-career scientists to help speed progress toward a cure for macular degeneration.
Annual awards recognize top-ranked grant recipients whose proposals show great promise to prevent, treat, and cure macular degeneration and glaucoma.
In recognition of Macular Degeneration Awareness Month, BrightFocus Foundation offers a variety of free educational resources to help individuals with macular degeneration and their loved ones navigate the disease.
Help Fight Macular Degeneration and Save Sight
Your donation helps fund critical research to bring us closer to a cure for this sight-stealing disease and provide vital information to the public.
Donate Today
